Format

Send to

Choose Destination
See comment in PubMed Commons below
Bioorg Med Chem. 2009 Mar 1;17(5):2069-76. doi: 10.1016/j.bmc.2009.01.025. Epub 2009 Jan 20.

18F-labeled flavones for in vivo imaging of beta-amyloid plaques in Alzheimer's brains.

Author information

1
Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

Abstract

In vivo imaging of beta-amyloid (Abeta) aggregates in the brain may lead to early detection of Alzheimer's disease (AD) and monitoring of the progression and effectiveness of treatment. The purpose of this study was to develop novel (18)F-labeled amyloid-imaging probes based on flavones as a core structure. Fluoropegylated (FPEG) flavone derivatives were designed and synthesized. The affinity of the derivatives for Abeta aggregates varied from 5 to 321nM. In brain sections of AD model mice, FPEG flavones with the dimethylamino group intensely stained beta-amyloid plaques. In biodistrubution experiments using normal mice, they displayed high uptake in the brain ranging from 2.9 to 4.2%ID/g at 2 min postinjection. The radioactivity washed out from the brain rapidly (1.3-2.0%ID/g at 30 min), which is highly desirable for beta-amyloid imaging agents. FPEG flavones may be potential PET imaging agents for beta-amyloid plaques in Alzheimer's brains.

PMID:
19201614
DOI:
10.1016/j.bmc.2009.01.025
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center